CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment / Bandinelli, F; Del Rosso, A; Gabrielli, A; Giacomelli, R; Bartoli, F; Guiducci, Serena; MATUCCI CERINIC, Marco. - In: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. - ISSN 0392-856X. - 30(2 Suppl 71):(2012), pp. S44-S49.
CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment
MATUCCI CERINIC, MARCO
2012-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.